Page last updated: 2024-11-01

omeprazole and Cognition Disorders

omeprazole has been researched along with Cognition Disorders in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kountouras, J1
Boziki, M1
Gavalas, E1
Zavos, C1
Grigoriadis, N1
Deretzi, G1
Tzilves, D1
Katsinelos, P1
Tsolaki, M1
Chatzopoulos, D1
Venizelos, I1

Trials

1 trial available for omeprazole and Cognition Disorders

ArticleYear
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.
    Journal of neurology, 2009, Volume: 256, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; B

2009